A carregar...
Proscillaridin A slows the prostate cancer progression through triggering the activation of endoplasmic reticulum stress
Prostate cancer (PCa) is the second commonly diagnosed malignancy in men over the world. Although androgen deprivation therapy for advanced PCa patients has significantly improved their survival, the majority of these patients eventually develop castration-resistant prostate cancer (CRPC). Proscilla...
Na minha lista:
| Publicado no: | Cell Cycle |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7100983/ https://ncbi.nlm.nih.gov/pubmed/32009541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1716484 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|